Is AbbVie (NYSE:ABBV) Gaining Momentum Among Institutional Investors?

3 min read | February 11, 2025 11:20 PM AEDT | By Team Kalkine Media

Is AbbVie (NYSE:ABBV) Gaining Momentum Among Institutional Investors? — Image source: Shutterstock

Institutional Interest in AbbVie

Wilmington Savings Fund Society FSB expanded its position in AbbVie Inc. (NYSE:ABBV) by 8.5% during the fourth quarter. The company disclosed in a filing with the Securities and Exchange Commission (SEC) that it now owns 89,190 shares after acquiring an additional 6,967 shares. At the end of the quarter, these holdings were valued at $15,849,000.

Other institutional investors and hedge funds have also made adjustments to their positions. Groupama Asset Management increased its position in AbbVie by 40.3% in the third quarter. The firm now holds 135,749 shares after acquiring an additional 38,974 shares. RPg Family Wealth Advisory LLC acquired a new position in the third quarter, and Fiduciary Advisors Inc. made a similar move in the fourth quarter. Additionally, Retirement Wealth Solutions LLC and Mizuho Securities Co. Ltd. also took new positions in AbbVie, with Mizuho Securities Co. Ltd. doubling its holdings in the third quarter.

Institutional Holdings and Strategic Adjustments

A significant portion of AbbVie’s ownership is concentrated among institutional investors, with approximately 70.23% of its shares currently held by these entities. The pharmaceutical company continues to attract institutional interest, as demonstrated by the adjustments made by various firms in recent quarters.

Groupama Asset Management’s increase in holdings suggests an enhanced commitment to the company. RPg Family Wealth Advisory LLC and Fiduciary Advisors Inc. have entered new positions, reflecting continued engagement from institutional entities. Retirement Wealth Solutions LLC has also made recent acquisitions, aligning with similar activity from other investors. Meanwhile, Mizuho Securities Co. Ltd. doubled its stake in the third quarter, reinforcing its position.

Broader Institutional Participation

The presence of institutional investors in AbbVie has been steadily growing. The pharmaceutical sector’s ongoing developments and innovations continue to attract financial institutions. Institutional adjustments in holdings indicate an evolving investment landscape within the sector.

AbbVie’s appeal among hedge funds and asset management firms remains strong, with multiple entities increasing their stakes or entering new positions. This pattern suggests a consistent level of engagement with the company’s developments.

Outlook for Institutional Involvement

With over 70% of its shares in the hands of institutional investors and hedge funds, AbbVie remains a significant entity in the pharmaceutical sector. Recent adjustments in holdings by prominent firms underscore ongoing interest from institutional entities. As financial institutions continue to refine their positions, the company’s standing within the sector remains under close observation.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.